- Home
- SPNT vs LGND Comparison
SPNT vs LGND Comparison
Compare SPNT & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPNT
- LGND
- Stock Information
- Founded
- SPNT 2011
- LGND 1987
- Country
- SPNT Bermuda
- LGND United States
- Employees
- SPNT N/A
- LGND N/A
- Industry
- SPNT Property-Casualty Insurers
- LGND Biotechnology: Pharmaceutical Preparations
- Sector
- SPNT Finance
- LGND Health Care
- Exchange
- SPNT Nasdaq
- LGND Nasdaq
- Market Cap
- SPNT 2.2B
- LGND 2.0B
- IPO Year
- SPNT N/A
- LGND 1992
- Fundamental
- Price
- SPNT $15.57
- LGND $112.59
- Analyst Decision
- SPNT
- LGND Strong Buy
- Analyst Count
- SPNT 0
- LGND 6
- Target Price
- SPNT N/A
- LGND $144.83
- AVG Volume (30 Days)
- SPNT 474.8K
- LGND 142.8K
- Earning Date
- SPNT 10-31-2024
- LGND 11-07-2024
- Dividend Yield
- SPNT N/A
- LGND N/A
- EPS Growth
- SPNT 31.47
- LGND 160.46
- EPS
- SPNT 1.60
- LGND 2.47
- Revenue
- SPNT $2,614,600,000.00
- LGND $152,422,000.00
- Revenue This Year
- SPNT N/A
- LGND $23.19
- Revenue Next Year
- SPNT N/A
- LGND $15.08
- P/E Ratio
- SPNT $9.31
- LGND $44.91
- Revenue Growth
- SPNT N/A
- LGND N/A
- 52 Week Low
- SPNT $10.34
- LGND $57.00
- 52 Week High
- SPNT $15.28
- LGND $129.90
- Technical
- Relative Strength Index (RSI)
- SPNT 71.41
- LGND 50.05
- Support Level
- SPNT $14.71
- LGND $109.53
- Resistance Level
- SPNT $15.10
- LGND $125.76
- Average True Range (ATR)
- SPNT 0.37
- LGND 5.37
- MACD
- SPNT 0.18
- LGND -1.17
- Stochastic Oscillator
- SPNT 96.72
- LGND 20.56
About SPNT SiriusPoint Ltd.
SiriusPoint Ltd provides property and casualty reinsurance coverage to insurance and reinsurance companies in the United States, Canada, Bermuda, the United Kingdom, and Europe. The company operates through two operating segments: Reinsurance and Insurance & Services. The company's product portfolio consists of reinsurance contracts for property insurance including both residential and commercial properties, workers' compensation, personal automobile, businesses' general liability insurance, professional liability insurance to protect professional advisors and service providers, agriculture insurance, and mortgage insurance. The majority of the revenue is generated from its Insurance & Services segment.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.